Medvin Clinical Research

Covina, California 91723

0 studies enrolling now · 43 studies all time

What they study most

Ankylosing Spondylitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, Rheumatoid, Chronic Gout, Chronic Kidney Disease (CKD), Chronic Uncontrolled Gout, Gout, Gout Flare, Hyperuricemia, Knee Osteoarthritis, Lupus Erythematosus, Systemic, Lupus Nephritis

Studies at this site

• A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — Recruiting now
• At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study] — Recruiting now
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis — Running, not enrolling
• 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee — Running, not enrolling
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — Completed
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy — Completed
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• A Study of Guselkumab in Participants With Active Lupus Nephritis — Stopped early
• Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis — Completed
• Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) — Completed
• Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain — Completed
• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy — Completed
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain — Completed
• A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy — Stopped early
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy — Stopped early
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
• Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome — Completed
• A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 — Completed
• Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) — Completed
• A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy — Stopped early
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) — Completed
• Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care — Status unconfirmed
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus — Stopped early
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
• Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study — Completed